Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study

The Journal of Infectious Diseases
Alessandro Cozzi-LepriItalian Cohort Naive Antiretrovirals (I.Co.N.A.) Study Group

Abstract

This nonrandomized study compared the virologic and immunologic responses to potent regimens containing either efavirenz or nevirapine after considering potential systematic differences between patients receiving these drugs. Virologic failure was defined as the first of 2 consecutive measurements of virus load >500 human immunodeficiency virus RNA copies/mL. Of the 694 patients included in the analysis, 460 (66.3%) started nevirapine and 234 (33.7%) started efavirenz. The adjusted relative hazard of virologic failure for patients who started nevirapine, compared with those who started efavirenz, was 2.08 (95% confidence interval, 1.37-3.15; P=.0006). In addition, patients receiving efavirenz tended to recover 5 CD4 cells/microL more per quarter (P=.05). Although comparisons of drug efficacy in nonrandomized studies should be viewed with caution, no results from randomized controlled comparisons of these drugs are thought to be available. The findings of this study are in agreement with those of other observational studies.

Citations

Feb 24, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M HartmannD Petzoldt
Jun 7, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thanyawee PuthanakitVirat Sirisanthana
Nov 27, 2008·AIDS Research and Human Retroviruses·Lindsay S RobisonMichael S Saag
Aug 17, 2011·The Journal of Infectious Diseases·Roger ParedesUNKNOWN EuroSIDA Study Group
Aug 30, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Graeme J Moyle
Nov 15, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Megan E O'BrienPatricia Kissinger
Mar 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Roberto ManfrediFrancesco Chiodo
Oct 21, 2006·AIDS·Sophie AbgrallUNKNOWN Clinical Epidemiology Group from the French Hospital Database on HIV
Jan 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Roberto ManfrediFrancesco Chiodo
Apr 9, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Naa Torshie AnnanJustin Stebbing
Apr 17, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mohammed Ishaaq DatayPatricia Yudkin
May 24, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xiuhong LiLisa P Jacobson
Mar 22, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew P FoxUNKNOWN IeDEA-SA collaboration
Jan 19, 2007·International Journal of Clinical Practice·L WatersM Nelson
Jan 5, 2010·Journal of Virological Methods·Elisa De CrignisDavide Gibellini
Apr 18, 2008·Statistics in Medicine·Bryan LauStephen J Gange
Feb 3, 2007·Expert Opinion on Pharmacotherapy·Miguel Goicoechea, Brookie Best
Apr 12, 2007·Expert Opinion on Pharmacotherapy·Saskia M E VrouenraetsJoep M A Lange
Mar 12, 2004·Expert Opinion on Pharmacotherapy·Zelalem TemesgenUNKNOWN Collaborative Research Network (CORNET) Investigators
Jun 25, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Keswadee LapphraKulkanya Chokephaibulkit
Jul 23, 2004·Antiviral Chemistry & Chemotherapy·Zhijun ZhangZhi Hong
Feb 13, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Massimo PuotiGiampiero Carosi
Nov 2, 2014·Journal of the International AIDS Society·Kate ShearerMatthew P Fox
Oct 16, 2004·Expert Review of Anti-infective Therapy·Azra C Ghani
Oct 16, 2004·Expert Review of Anti-infective Therapy·Claude Fortin, Veronique Joly
Aug 2, 2003·AIDS·Amanda MocroftUNKNOWN EuroSIDA study group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.